Millennium Management’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-963,011
| Closed | -$2.47M | – | 4311 |
|
|
2025
Q1 | $2.47M | Buy |
963,011
+575,090
| +148% | +$1.47M | ﹤0.01% | 2458 |
|
|
2024
Q4 | $729K | Buy |
387,921
+14,164
| +4% | +$26.6K | ﹤0.01% | 3070 |
|
|
2024
Q3 | $381K | Sell |
373,757
-437,403
| -54% | -$446K | ﹤0.01% | 3449 |
|
|
2024
Q2 | $949K | Buy |
811,160
+800,676
| +7,637% | +$937K | ﹤0.01% | 2895 |
|
|
2024
Q1 | $13.2K | Buy |
+10,484
| New | +$13.2K | ﹤0.01% | 4002 |
|
|
2023
Q3 | – | Sell |
-21,232
| Closed | -$42.5K | – | 4478 |
|
|
2023
Q2 | $42.5K | Sell |
21,232
-65,466
| -76% | -$131K | ﹤0.01% | 3984 |
|
|
2023
Q1 | $182K | Buy |
+86,698
| New | +$182K | ﹤0.01% | 3892 |
|
|
2022
Q3 | – | Sell |
-19,223
| Closed | -$21K | – | 5432 |
|
|
2022
Q2 | $21K | Buy |
+19,223
| New | +$21K | ﹤0.01% | 4937 |
|
|
2017
Q1 | – | Sell |
-11,010
| Closed | -$49K | – | 3474 |
|
|
2016
Q4 | $49K | Buy |
+11,010
| New | +$49K | ﹤0.01% | 3038 |
|
|
2013
Q4 | – | Sell |
-3,439
| Closed | -$156K | – | 2773 |
|
|
2013
Q3 | $156K | Buy |
3,439
+1,734
| +102% | +$78.7K | ﹤0.01% | 2414 |
|
|
2013
Q2 | $84K | Buy |
+1,705
| New | +$84K | ﹤0.01% | 2407 |
|